Bioequivalence evaluation of two brands of lisinopril tablets (Lisotec and Zestril) in healthy human volunteers

The bioequivalence of two brands of lisinopril 20 mg tablets was demonstrated in 28 healthy human volunteers after a single oral dose in a randomized cross‐over study, conducted at ACDIMA Center for Bioequivalence and Pharmaceutical Studies, Amman, Jordan. Reference (Zestril, AstraZeneca, UK) and te...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Biopharmaceutics & drug disposition 2005-11, Vol.26 (8), p.335-339
Hauptverfasser:	Tamimi, J. J. I., Salem, I. I., Alam, S. Mahmood, Zaman, Q., Dham, Ruwayda
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Angiotensin-Converting Enzyme Inhibitors - administration & dosage Angiotensin-Converting Enzyme Inhibitors - pharmacokinetics bioequivalence Biological and medical sciences Cross-Over Studies HPLC Humans Julphar lisinopril Lisinopril - administration & dosage Lisinopril - pharmacokinetics Medical sciences pharmacokinetics Pharmacology. Drug treatments Tablets Therapeutic Equivalency
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!